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1. Introduction
Hemodialysis has been used for half a century and is often proposed as the first support treat‐
ment for patients developing end-stage renal disease, more frequently than peritoneal dialy‐
sis and kidney transplantation. For a large part, the success of hemodialysis depends on the
success of the vascular access, whether achieved with an arteriovenous fistula or a central ve‐
nous catheter. Survival of the vascular access often determines the patient’s survival, empha‐
sizing the importance of carefully preserving the often limited stock of available vascular
tissue. The purpose of this chapter is to review the different possibilities for vascular access
for hemodialysis, from planning to construction, including a discussion on the importance of
complementary explorations for complex situations or complications. Clinical cases will be
presented to illustrate how multidisciplinary management can meet the challenge of desper‐
ate “last chance” situations, providing lifesaving solutions for our patients.
2. Vascular access for hemodialysis: Background
Vascular access should enable obstacle-free blood flow for the extra corporeal hemodialysis
circuit with appropriate inflow and outflow pressures (Figure 1). In addition, vascular ac‐
cess should not cause any deleterious consequences for the patient such as limb ischemia re‐
lated to steal phenomena, stasis edema or compressive effects (for instance in the head and
neck) due to a peripheral or central stenosis blocking venous backflow. An excessive flow
rate can compromise cardiac function. Several types of vascular access are available, with
two modalities: catheter and fistula. In the past, the first hemodialysis systems used an ex‐
ternal shunt made by inserting canulas into an artery and a vein (lower or upper limbs), for
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example the Thomas shunt [1], creating an extracorporeal circulation. In the sixties, im‐
proved techniques allowed the creation of the first arteriovenous fistula (AVF), an anasto‐
motic bypass between an artery and a vein [2]. AVFs may be positioned on the upper limb
or the lower limb, proximally or distally. Single or double-flow central venous catheters may
also be inserted into the large veins of the neck or thigh, with or without tunnelization.
Figure 1. Hemodialysis circuit (From T. Cao-Huu with permission)
3. Catheter or arteriovenous fistula (AVF): The rationale
A central venous catheter may be used for vascular access in emergency situations in pa‐
tients unprepared for hemodialysis or if an intercurrent event, for example thrombosis of
the AVF, infection or any situation contraindicating the usual access, occurs in a patient al‐
ready on hemodialysis. Insertion of a central catheter has the advantage of offering immedi‐
ate high-flow vascular access but should, according to the guidelines issued by the National
Kidney Foundation Kidney Disease Outcome Quality Initiative (KDOQI), be used in less
than 10% of patients [3]. Data from the United States Renal Data System (USRDS) however
revealed that in 2009 more than 80% of patients started dialysis with a central catheter. Prac‐
tices in Europe and the United States differ as shown by the DOPPS study which, after ad‐
justment for confounding factors, compared vascular access practices, focusing on particular
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factors associated with use of a native AVF versus graft or catheter [4]. The prevalence of
native AVF use was found to be 80% in Europe versus 24% in the US. At dialysis onset, 66%
of European patients had an AVF (including 2% with a prosthetic graft) versus 15% in the
US [24% prosthetic graft). Patient referral patterns, nephrological follow-up and the type of
vascular access used are directly related: closely monitored patients are better prepared for
dialysis. There is also an economic element, related to general population access to health‐
care [5].
It is argued that more complications occur with a catheter than with an AVF [6-10]. A re‐
view of the literature confirms the superiority of the native AVF over prosthetic material or
catheters. Longer life, fewer mechanical complications (thrombosis, stenosis), and lower in‐
fectious risk are advantages of the native AVF. It is the recommended vascular access, and
should be considered as the gold standard [3][10][11].
Quality-of-life [12] and morbidity-mortality risk, especially in the elderly [13], are directly
related to the type of vascular access first used for dialysis. There is a real advantage if the
first vascular access is a native or graft AVF [14]. Survival is also improved [15].
A central catheter may however be quite useful for temporary (or permanent) vascular ac‐
cess in particular situations: living-donor graft involvement; short life expectancy (cancer);
waiting for an AFV to mature; permanent access despite a highly deteriorated vascular sys‐
tem; heart failure; severe arteriopathy with risk of steal phenomena [16]. For the congestive
heart failure patient, preemptive construction of an AVF has been shown to be a source of
decompensation[17].
4. Choosing a vascular access for hemodialysis
4.1. Catheter
4.1.1. Types used
Catheters have been carefully designed to respond to the needs of the dialysis patient. Pre‐
requisites include appropriate flow rate and clearance quality (diameter, separate branches,
multiperforated tip), physical resistance (flexibility/rigidity, composing material: silicone,
polyurethane…), tolerance (internal medium, blood/material interactions, surfacing process‐
es), and cosmetic acceptability. Portacaths and tunnelization have been used since 1987,
greatly reducing the risk of infection by increasing the distance between the point of entry
into the central vein and the point of exit through the skin [18] (Figure 2).
To access central veins, priority should be given to jugular (and secondarily infraclavicular)
puncture to reach the superior vena cava, first on the right side, and secondarily on the left
side. Access to the inferior vena cava, via a femoral or translumbar puncture, should always
be a second-intention procedure.
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 Figure 2. Example of a cuffed catheter (From B. Canaud with permission)
4.1.2. Technical modalities
There are a certain number of clinical prerequisites for catheter insertion. Attention must be
given to the patient’s history of vascular access and potential problems or anomalies, the
risk of stricture often revealed by collateral circulation, and the presence of edema.
Ultrasound guidance has a proven impact on reducing the risk of complications [19]. The
pitfalls of blind puncture (anatomic variations or unknown strictures or thrombi) may be
avoided. This may be especially important in catheter-naïve patients or those with a past
history of vascular access.
Hemostasis should be checked. Treatments (anticoagulants) and specific clinical features
(hemodynamic situation, respiratory function, general status) should be noted before at‐
tempting to position a central catheter.
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A chest X-ray may be useful during catheter insertion but in general is obtained in the radi‐
ology unit after completing the procedure. Local practices depend on available facilities
(catheter insertion feasible in the radiology unit?).
Catheter  maintenance  is  a  multifactorial  process.  Rigorous  aseptic  manipulation  is  the
rule.  Different  types  of  impregnated locks  can be  proposed depending on the  objective
[20]:  anticoagulation,  fibrinolysis,  anti-infectious  or  anti-septic  effect  (tauludine,  citrate).
The  debate  continues  concerning  the  longevity  of  non-tunnelized  catheters:  guidelines
vary from 1 to  3  weeks.  These catheters  are  however  often used for  much longer  peri‐
ods of time. It  is also generally accepted that tunnelized catheters should be a tempora‐
ry  option  while  waiting  for  the  maturation  of  an  AVF,  although  clinical  practice  may
dictate  using  them  as  the  permanent  vascular  access  (AVF  unfeasible,  frail  elderly  pa‐
tient) [21].
4.1.3. Acute complications
Different  types  of  acute  intra-operative  complications  are  noted:  hemorrhage,  traumatic
arterial or venous puncture with vessel laceration, pneumothorax, hemothorax, air embo‐
lism, dysrhythmia, neurological injury, malposition [22-24].
4.1.4. Long-term complications [25]
Long-term complications are usually related to the duration of use and insertion [26] and
in general affect the quality of dialysis. According to the KDOQI, catheter dysfunction is
defined as blood flow <300ml/min and blood pressure >250 mmHg [3].  There are many
causes  related  to  mechanical  problems  or  clot  formation.  Mechanical  obstruction  may
arise if the catheter is folded or malpositioned (a catheter is considered to be too short or
too  long depending on  the  position  of  the  tip  in  relation  to  the  right  atrium).  Clotting
may result from a blood-material interaction leading to progressive formation of a fibrin
sheath around the catheter.  Blood clots may also form at the tip of the catheter because
of  perturbed blood flow or  microtrauma.  This  is  the  leading cause of  catheter  dysfunc‐
tion [27].
Infection is  another important  complication.  A venous catheter  constitutes a  portal  with
the inherent risk of colonization and dissemination.  In the chronic hemodialysis patient,
it is the leading source of infection [28], which in turn is the leading cause of morbidity
and mortality [29].
Central veins repeatedly exposed to catheters may develop zones of stenosis [30]. The hy‐
pothesized pathogenic mechanism would involve repeated microtrauma injuring the en‐
dothelium, turbulent blood flow, local uremic context related to the renal failure, chronic
inflammation,  and activation of  the coagulation cascade.  The use of  the left  side would
have an impact since the catheter has to be longer and local anatomic conditions are less
favorable (compression).  Similarly,  complications would be more common after infracla‐
vicular puncture compared with jugular puncture due to the anatomic configuration.
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4.2. Arteriovenous fistula
4.2.1. Types used
Several types of AVF are proposed (Figure 3), using different upper or lower limb arteries
and veins, with or without a graft (straight forearm graft, looped-shape graft). Beyond ves‐
sel quality and the patient’s past history and clinical situation, the only limitation for fistula
configuration appears to be the creativity of the nephrologist and surgeon [31] (Figure 4).
 
Figure 3. Native and prosthetic arteriovenous fistulas (from T Cao-Huu with permission)
Figure 4. Map of forearm vessels (from T Cao-Huu with permission)
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One question often raised is whether the patient’s endogenous vasculature or a prosthetic
graft should be preferred. Most clinicians prefer to reserve prosthetic grafts as a second in‐
tention option after failure of one or more native AVF, or if the existing vascular network is
unusable, as a first intention proposal. The advantage is that native AVFs mature more rap‐
idly and offer easier more effective surgical access should a thrombotic event occur [32]. One
retrospective study found that the risk of access failure is higher with a graft compared with
a native AVF [33], both for first and second intention accesses. Greater longevity, better
quality and fewer surgical revisions are all advantages of the native AVF over the graft [34].
If a native AVF is not feasible, a graft would be superior to a central catheter in terms of
complications, although opinions have varied [36]. The Flixene graft composed of synthetic
material (PTFE) is easy to puncture. To date, there has not been any clinical study compar‐
ing mechanical complications with Flixene and vascular grafts.
4.2.2. Technical modalities
The construction of a vascular access for hemodialysis is a crucial event affecting the pa‐
tient’s  quality-of-life  and survival.  European and American guidelines have been issued
[37][38].
Several parameters and pre-operative explorations must be taken into account [38][39]:
• Patient characteristics: genetic background, age, dominant hand, spare vessels, co-morbid
conditions (diabetes, arteriopathy), status of venous network, prior attempts to form an
access, presence of a pacemaker, coagulation disorders, heart failure (risk of decompensa‐
tion if the fistula flow rate is too high), possibility for anesthesia, patient education, future
renal transplantation (waiting list, blood group, anti-HLA immunization, projected liv‐
ing-donor graft);
• Physical examination: vessel map and vessel characteristics [40], signs of collateral circu‐
lation or edema suggesting possible strictures, Allen maneuver to search for steal phe‐
nomena and other vascular functions [41];
• Imaging findings: ultrasound, computed tomography angiogram;
• Biochemical parameters would also have an impact although formal evidence is lacking
[42];
• Physician experience and training (nephrologist and surgeon) also affect outcome [43].
A recent study showed that according to the responding nephrologists, selection criteria for
AVF candidates are quite variable. No consensus has been reached concerning the appropri‐
ate indications and contraindications for creating an AVF [44].
4.2.3. Acute complications
Early complications are mainly related to the operative procedure and include hematoma,
operative site infection, defective wound healing, and neurological problems.
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4.2.4. Long-term complications [45]
Complications occurring late are also quite variable: retarded maturation requiring collater‐
al ligation to favor development; need to change the site of anastomosis; a vein too deep for
puncture (e.g. superficialization of a humerocephalic AVF); bleeding; ischemia related to
steal phenomena; flow rate too high for cardiac output requiring a smaller caliber or a DRIL
procedure); aneurismal or necrotic lesions related to puncture; thrombotic events and stric‐
tures of the AVF itself or of the central veins. No direct link between daily dialysis sessions
and complication rate has been demonstrated [46]. Infection is also a serious complication,
sometimes diffusing to multiple sites (endocarditis, spondylodiscitis).
4.2.5. Good clinical practices for AVF [38][37]
As a rule, a good AVF will exhibit optimal development. This means avoiding complica‐
tions and treating those which do develop early. It also means limiting the risk of thrombo‐
sis and stricture by avoiding the use of venous access in emergency situations. The site
chosen for the AVF should be as distal as possible in order to facilitate puncture and spare
more proximal veins for later use if needed. The AVF should be on the dominant side.
What is an ideal AVF? According to both the American [38] and European [37] guidelines,
the first-intention AVF should be native and distal. Case-by-case decision making neverthe‐
less determines the optimal configuration: e.g. a proximal fistula because of an insufficient
distal network; a distal fistula to avoid high flow rate in a patient with heart failure; a syn‐
thetic graft or a central venous catheter in a patient with poor vessel quality.
When should the AVF be constructed? Considering past experience and available evidence,
concerted action has been undertaken in several countries to increase the proportion of first-
intention AVFs used for hemodialysis vascular access [47-49]. No consensus has been
reached concerning the optimal position for the AVF in the end-stage renal disease dialysis
patient. The decision depends on how fast the kidney disease progresses, and the availabili‐
ty of healthy arterial and venous tissue. In the emergency context, a temporary access may
have to be created rapidly, followed by a final configuration determined later: position of
the permanent vascular access, option for peritoneal dialysis, etc[37].
When can an AVF be punctured? According to the KDOQI [3], indicators of optimal matura‐
tion include flow rate >600 ml/m and 6-mm inner diameter. In clinical practice, operator skill
greatly affects the decision to use an AVF or not, and consequently, its longevity. Good clini‐
cal practices focus on local hygiene and puncture technique (button-hole puncture, compres‐
sion after needle withdrawal). Care must be taken to avoid infections, aneurysms or necrotic
tissue and strictures. Several studies have compared the use of the button-hole option versus
a rotation of the puncture points. Results have been discordant concerning the advantages
and disadvantages of the two methods (pain, ease of puncture, infection rate) [50, 51]. There
is also the question of the number of needles. Unipuncture can be useful if the fistula cannot
be punctured readily or if it is too short to insert two needles. It can also be a solution if a
bipuncture venous catheter cannot be inserted. Well performed, unipuncture can enable
good quality dialysis, with equivalent morbidity and mortality compared to the bipuncture
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technique. Data are lacking concerning a potential reduction in the complication rate with
unipuncture.
How should the AVF be monitored? Various methods can be used to check vascular access
function and detect the development of complications: physical examination, education of
patients and nurses, venous pressure, blood recirculation and flow rate, clearance (kt/v), du‐
plex Doppler, CTangiogram, or fistulography, which can be performed with or without
compression, particularly to identify steal phenomena. Combining these explorations often
provides complementary information. The KDOQI proposes a basic algorithm for monitor‐
ing these elements [38]. A software based on impedancemetry combined with tomography
angiography is an innovative technology allowing study of flow rates and pressures within
the AVF and thus early detection of potential complications [52].
5. Multidisciplinary management: Key to success
Nephrologists, radiologists, and vascular surgeons working together to find the most appro‐
priate solution for each individual patient, before, during and after construction of the vas‐
cular access is the key to success. The goal is to achieve the best possible vascular access
which will survive as long as possible.
In the following sections, we present a few examples of patients referred to our center with a
failing vascular access. These ‘desperate’ cases illustrate how audacious solutions may be
found for lifesaving vascular access.
5.1. Catheter failure
5.1.1. General statement
Catheter failure generally occurs in patients who have had several catheters or when AVF is
no longer feasible. Mechanical complications are however becoming less and less common
because of the greater flexibility and longer stability provided by the new materials: polyur‐
ethane and silicone. Neither material has proven superiority over the other [18].
In the past, immediate withdrawal was the rule when infection developed in a catheter-
bearing patient. This is still the basic attitude for non-tunnelized catheters. If however the
catheter is tunnelized, most clinicians now consider that a probabilistic antibiotic regimen
can be initiated in combination with aseptic wash-out (skin orifices, subcutaneous tunnel).
An antibiotic lock is also useful. If the course is unfavorable (poor control of infection mark‐
ers, secondary spread), the catheter must be withdrawn rapidly [53].
In general, for a non-tunnelized catheter, thrombus-related complications (clot formation
within the catheter, fibrin sheath) are treated by withdrawal. For a tunnelized catheter,
thrombolytic agents (urokinase) are often used. Short-term results have been satisfactory,
but long-term results less so [54]. To prevent recurrence, thrombolysis may be associated
with oral anticoagulants or antiplatelet agents, but to date no real indication has been identi‐
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fied in this context and no consensus can be established from the currently available studies.
There is no evidence supporting the efficacy of preventive treatment for AVF or central vein
thrombotic events or strictures [55]. Salvage (mechanical extraction of a fibrin plug or blood
clot) can be attempted with angioplasty equipment and balloons. Results have been promis‐
ing [56, 57]. The KDOQI recommends extraction with catheter replacement [3].
For stenosis of the central veins, percutaneous angioplasty, with or without stenting, is pre‐
ferred, especially for recurrent stenosis [58].
5.1.2. Illustrative cases: Failing vascular access due to multiple strictures of the central veins and
catheter dysfunction
Case n° 1: a large number of old thrombi obstructing the central veins and preventing cathe‐
ter insertion. The problem was solved using a novel interventional radiology technique per‐
formed in cooperation with the vascular surgery team.
A 52-year-old obese woman with diabetes was referred for failing vascular access after loss
of a kidney graft subsequent to non-compliance. Over the last five years, 12 central catheters
(jugular and femoral access) had been used for dialysis. All attempts to fashion an AVF, on
the right and on the left, had failed. The most recent central catheter was tunnelized but
failed due to thrombi in both brachiocephalic venous trunks (Figure 5). Several dilatation at‐
tempts had failed.
Figure 5. Thrombi in both brachiocephalic venous trunks; one was recent and long (yellow arrow); the older one was
shorter (red arrow) (From T.Cao-Huu with permission)
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The patient was referred with a tunnelized left femoral catheter complicated by a long
thrombus in the right femoral vein. Imaging showed patent right subclavian and right ceph‐
alic veins so that a homolateral upper limb AVF would be feasible. In order to maintain the
hemodialysis after constructing the AVF and waiting for it to mature, another angioplasty
procedure was attempted to overcome the 1-cm obstruction in the right brachiocephalic
trunk. Using an innovative “rendez-vous” technique, probes inserted via the femoral and
jugular veins were passed through the obstruction and joined to dilate the stricture and in‐
sert a stent then a catheter. The procedure was performed under general anesthesia by a ra‐
diologist with a vascular surgeon back-up if necessary (Figure 6 and 7).
Figure 6. Dual access (10F) via the right common femoral vein and the right internal jugular vein. The right internal
jugular probe was positioned on the superior aspect of the obstruction (green arrows). A lasso catheter was inserted
via the femoral access up to the inferior aspect of the obstruction (blue arrows). Biplanar analysis showed the proximi‐
ty of the two probes. A Chiba 23G needle (black arrows) was inserted via the jugular probe to puncture the thrombus.
A 0.0014 In (yellow arrow) guidewire was fed through the Chiba needle and captured by the inferior lasso. (From
T.Cao-Huu with permission)
Figure 7. After 8, 10, and 12 mm balloon dilatations ⇒  12-cm self-expansive stent completed with a 12-mm balloon.
(From T.Cao-Huu with permission)
This patient was dialysed on her cuffed catheter and died about one year later, from a coro‐
nary disease.
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Case n° 2: a problem of central venous stenosis solved by dilatation (and stenting) then sec‐
ondary catheter insertion.
A 23-year-old patient who had developed cutaneous graft-versus-host disease after a bone
marrow graft for leukemia was referred for calciphylaxia and very poor general status. At
admission the work-up showed poor dialysis parameters and low flow rate from a left radi‐
al-radial native AVF. There were multiple arterial and venous strictures and a risk of hand
ischemia. The angiogram visualized very frail calcified forearm arteries and thrombi in the
left cubital artery, the left jugular vein, and the right brachiocephalic venous trunk. A multi‐
disciplinary meeting with radiologists and vascular surgeons led to the decision to attempt
stenting the right brachiocepahlic venous trunk to insert two tunnelized catheters after dila‐
tation (Figure 8).
 
Figure 8. Angioplasty and stenting of the stenosed right brachiocephalic venous trunk. (From T.Cao-Huu with permis‐
sion)
The angioplasty was successful allowing intensified hemodialysis and associated treatment
of the calciphylaxia (disodium thiosulfate) in preparation for renal transplantation, consid‐
ered as an “emergency” procedure due to the failing vascular access and the calciphylaxia.
Outcome was favorable, both for the kidney graft and the calciphylaxia.
5.2. Fistula failure: Multiple stenoses affecting the upper limb venous network and both
central veins
Treatments for aneurismal complications, late fistula maturation, ischemia or high flow rate
are well known and will not be discussed here. This chapter will focus on stenotic complica‐
tions involving the fistula itself or the central veins and situations of failing vascular access
Hemodialysis730
in patients who often have had a long history of successive attempts to create functional vas‐
cular accesses.
5.2.1. General statement [59]
Evidence in the literature on patients prepared for hemodialysis with an AVF is formal: after
adjustment for confounding factors, AVF survival is inversely proportional to the number of
interventions needed to render it usable [60].
Two cases in our center have illustrated the negative impact of catheter-related stenosis of
the central veins on vascular access. Treatment relies heavily on interventional radiology
[61, 62].
In addition to the imaging explorations mentioned above, stenosis of the AVF can be detect‐
ed clinically by measuring fistula flow rate during dialysis [63]. Patient and caregiver educa‐
tion is essential here. Invasive diagnostic procedures are not recommended per se and
increase the cost of treatment, but if a stenosis is suspected clinically, further explorations
should be undertaken to prevent the development of significant thrombosis [64]. To date,
studies have been unable to demonstrate any difference in the long-term outcome of the fis‐
tula between surgery for thrombosis and pre-thrombotic treatment [65].
Angioplasty is the treatment of choice for fistula stenosis; stenting is optional. Various types
of material have been tested. Ultra-high pressure balloons or cutting balloons can remove
the atheroma from the vessel wall mechanically, but with the risk of vessel tears. Metallic
stents can be coated with different surfacing agents to improve their longevity. Self-expand‐
able stents are successful in only one-third of cases, but with no real impact on long-term
AVF survival [66, 67].
A recent review [68] detailed the different phases of the interventions: angioplasty for steno‐
sis of pre-thrombotic AVF and thrombectomy for thrombotic AVF (pressure or mechanical
removal depending on the nature of the thrombus) followed by angioplasty if an associated
stenosis is identified; systematic exploration of the central vascular network in order to
avoid missing any stenosis-favoring stricture accessible to angioplasty. Short-term pharma‐
cological treatment (anticoagulant, antiplatelet agents) may be useful.
5.2.2. Illustrative cases: Steal syndrome and last chance access
Case n°1: chronic hand ischemia in a 77-year-old patient with upper limb arteriopathy.
A Distal Revascularization Interval-Ligation (DRIL) (Figure 9) procedure was performed to
reperfuse the distal arteries and save the fistula. Revascularization was achieved with a radi‐
al-radial bypass combined with ligation of the radial artery. It allowed a long term fistula,
hand and patient survival. Other types of revascularization (e.g. prolongations) can also be
proposed.
Case n° 2: extensive central venous stenosis involving the vena cava combined with intracar‐
diac thrombotic formations treated with interventional radiology, avoiding thoracotomy for
major heart surgery and preserving the vascular access.
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This 56-year-old patient on chronic hemodialysis for uropathy subsequent to multiple trau‐
ma (traffic accident) had already had several central catheters and distal AVFs when he was
referred to our unit for low flow rate in the right forearm gortex graft with central vein
thrombus involving the superior vena cava. The final decision was to combine heparin with
radiologic angioplasty because of the high risk of heart surgery. The successful intervention
illustrates how the potentially serious consequences of a long history of vascular accesses
can be resolved. This patient is still on hemodialysis, on his goretex graft that well work.
Figure 9. DRIL. (From T.Cao-Huu with permission)
Case n° 3: a young patient with recurrent fistula stenosis compromising the last dialysis ac‐
cess available.
This 26-year-old patient on hemodialysis since childhood for malformativeuropathy had
had a kidney transplant before returning to hemodialysis due to non-compliance with drug
regimen. He had a right tunnelized catheter for hemodialysis because successive attempts to
fashion an AVF had failed. Thrombi developed bilaterally in the internal jugular vein, in the
left brachiocephalic venous trunk and in the superior vena cava. Multiple episodes of cathe‐
ter dysfunction occurred requiring successive replacements, complicated by repeated infec‐
tions. Despite the very poor venous network and a very frail cubital vein, the vascular
surgeon successfully created a right cubital AVF after repeated procedures to carefully di‐
late juxta-anastomic strictures. Hemodialysis was continued for more than two years via this
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fragile fistula while waiting for the progressive development of the basilic vein and subse‐
quent construction and maturation of a humerobasilicgortex bypass. Despite recurrent
stenosis with thrombus formation favored by a fold in the graft assembly at the elbow, the
patient’s hemodialysis protocol was conducted successfully until a second kidney graft
could be implanted. This graft has a favorable outcome, but the patient has lost his fistula.
This case illustrates the important contribution of an experienced vascular surgery team ca‐
pable of creating a fistula with very little viable tissue.
The long term prognosis of these “difficult” patients is not easy to evaluate. With time these
patients have also a high cardiovascular risk and even if an access for hemodialysis is suc‐
cessfully created, some of them died from a cardiovascular event. It reflects the links be‐
tween the vascular deadlock and the global vascular risk.
6. Conclusion
Vascular access is vital for end-stage renal disease patients on hemodialysis. Many solutions
are available, but careful decision making is crucial. A good vascular access could be de‐
fined as one avoiding serious complications and multiple surgical and radiological interven‐
tions. There is always a risk of complications, but with an adequate physical examination,
appropriate imaging and multidisciplinary management involving the nephrologist, the in‐
terventional radiologist and the vascular surgeon, an optimal solution can be found to pro‐
long the life of an existing access or fashion an ingenious new access, even for the most
desperate “last chance” cases. A few cases observed in our center illustrate this need for a
multidisciplinary approach to patient management, focusing not only on vascular access it‐
self, but also its complications and their prevention.
It is clear that before opting for a central catheter, an arteriovenous fistula should be at‐
tempted whenever feasible, even for the most difficult cases. The optimal moment to create
the arteriovenous fistula remains a difficult decision which can be made only after global as‐
sessment of all potential candidates, i.e. not only patients scheduled for prolonged hemo‐
dialysis but also those followed for kidney failure, keeping in mind the major objective of
preserving the vascular network.
At the present time, the most innovating development remains the arteriovenous fistula
conceived by Brescia in 1966. There has been no change in this gold standard, but there has
been in our patients who have become older and frailer, a real challenge for multidisciplina‐
ry teams.
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